Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression

Area of Science:

• Neuroscience
• Microbiology
• Proteomics

Background:

• Major depressive disorder (MDD) is a significant mental illness.
• The gut-brain axis and gut microbiota are increasingly implicated in depression.
• Mechanisms underlying gut microbiota's role in depression are not fully understood.

Purpose of the Study:

• To investigate protein expression changes in the gut-brain axis modulated by gut microbiota in a depression model.
• To identify specific protein alterations in response to gut microbiota transplantation from MDD patients.

Main Methods:

• Germ-free mice received gut microbiota from MDD patients to induce depression-like behaviors.
• Quantitative proteomics analyzed protein expression in the prefrontal cortex, liver, cecum, and serum.
• Differential protein analysis and weighted gene coexpression network analysis identified key protein modules.

Main Results:

• Gut microbiota transplantation altered protein expression across multiple gut-brain axis tissues in mice exhibiting depression-like phenotypes.
• Prefrontal cortex and liver protein changes were specific to this microbiota-induced model, distinct from chronic stress models.
• Gene ontology analysis indicated involvement in metabolic processes and inflammatory responses, with energy metabolism as a core network change.

Conclusions:

• Gut microbiota significantly influences protein expression within the gut-brain axis.
• These protein alterations, particularly in metabolism and inflammation, are linked to depression-like behaviors.
• The study provides protein-level insights into the gut microbiota's role in depression pathogenesis.